Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$10.78 - $17.73 $1.15 Million - $1.89 Million
-106,374 Reduced 89.96%
11,871 $142,000
Q1 2023

May 12, 2023

SELL
$13.02 - $19.87 $720,683 - $1.1 Million
-55,352 Reduced 31.89%
118,245 $1.54 Million
Q4 2022

Feb 13, 2023

SELL
$7.65 - $15.51 $1.22 Million - $2.47 Million
-159,372 Reduced 47.86%
173,597 $2.57 Million
Q3 2022

Nov 10, 2022

BUY
$8.63 - $15.52 $146,770 - $263,948
17,007 Added 5.38%
332,969 $2.95 Million
Q2 2022

Aug 11, 2022

SELL
$8.59 - $20.77 $19,516 - $47,189
-2,272 Reduced 0.71%
315,962 $3.99 Million
Q1 2022

May 13, 2022

BUY
$15.52 - $35.65 $1.63 Million - $3.75 Million
105,134 Added 49.34%
318,234 $6.02 Million
Q4 2021

Feb 14, 2022

BUY
$28.89 - $35.33 $1.23 Million - $1.5 Million
42,549 Added 24.95%
213,100 $7.48 Million
Q3 2021

Nov 12, 2021

BUY
$35.66 - $42.94 $2.91 Million - $3.51 Million
81,634 Added 91.81%
170,551 $6.24 Million
Q2 2021

Aug 13, 2021

SELL
$23.7 - $39.27 $57,922 - $95,975
-2,444 Reduced 2.68%
88,917 $3.49 Million
Q1 2021

May 14, 2021

SELL
$27.01 - $36.8 $798,091 - $1.09 Million
-29,548 Reduced 24.44%
91,361 $2.58 Million
Q4 2020

Feb 12, 2021

BUY
$27.51 - $34.36 $275,210 - $343,737
10,004 Added 9.02%
120,909 $3.87 Million
Q3 2020

Nov 13, 2020

BUY
$25.8 - $34.61 $935,482 - $1.25 Million
36,259 Added 48.57%
110,905 $3.58 Million
Q2 2020

Aug 12, 2020

BUY
$17.65 - $28.05 $1.03 Million - $1.64 Million
58,513 Added 362.69%
74,646 $2.06 Million
Q1 2020

May 14, 2020

SELL
$15.19 - $29.51 $10,465 - $20,332
-689 Reduced 4.1%
16,133 $288,000
Q4 2019

Feb 13, 2020

BUY
$17.17 - $25.95 $5,563 - $8,407
324 Added 1.96%
16,822 $422,000
Q3 2019

Nov 13, 2019

BUY
$17.84 - $22.69 $27,990 - $35,600
1,569 Added 10.51%
16,498 $294,000
Q2 2019

Aug 13, 2019

BUY
$22.0 - $31.78 $328,438 - $474,443
14,929 New
14,929 $328,000

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.